Phenoxybenzamine hydrochloride is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Phenoxybenzamine Hydrochloride.
| Product ID | 60219-1502_436bc80c-4a53-4617-9f55-be5096b40b82 |
| NDC | 60219-1502 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Phenoxybenzamine hydrochloride |
| Generic Name | Phenoxybenzamine Hydrochloride |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-10-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA212568 |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Substance Name | PHENOXYBENZAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-10-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0349 | Phenoxybenzamine Hydrochloride | Phenoxybenzamine Hydrochloride |
| 49884-038 | Phenoxybenzamine Hydrochloride | Phenoxybenzamine Hydrochloride |
| 60219-1502 | Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride |
| 66993-066 | Phenoxybenzamine Hydrochloride | Phenoxybenzamine Hydrochloride |
| 69238-1502 | Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride |
| 70954-365 | Phenoxybenzamine Hydrochloride | Phenoxybenzamine Hydrochloride |
| 59212-001 | Dibenzyline | Phenoxybenzamine Hydrochloride |